DK0988861T3 - Stabiliserede proteinpræparater - Google Patents

Stabiliserede proteinpræparater

Info

Publication number
DK0988861T3
DK0988861T3 DK99306262T DK99306262T DK0988861T3 DK 0988861 T3 DK0988861 T3 DK 0988861T3 DK 99306262 T DK99306262 T DK 99306262T DK 99306262 T DK99306262 T DK 99306262T DK 0988861 T3 DK0988861 T3 DK 0988861T3
Authority
DK
Denmark
Prior art keywords
protein preparations
stabilized protein
stabilized
preparations
protein
Prior art date
Application number
DK99306262T
Other languages
Danish (da)
English (en)
Inventor
Peter Connor Canning
Barbara Jean Pfizer C Kamicker
Kasra Pfizer Central Kasraian
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Application granted granted Critical
Publication of DK0988861T3 publication Critical patent/DK0988861T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/193—Colony stimulating factors [CSF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Endocrinology (AREA)
  • Oncology (AREA)
  • Pulmonology (AREA)
  • Reproductive Health (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Diabetes (AREA)
  • Communicable Diseases (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DK99306262T 1998-08-17 1999-08-06 Stabiliserede proteinpræparater DK0988861T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US9687698P 1998-08-17 1998-08-17

Publications (1)

Publication Number Publication Date
DK0988861T3 true DK0988861T3 (da) 2004-04-19

Family

ID=22259521

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99306262T DK0988861T3 (da) 1998-08-17 1999-08-06 Stabiliserede proteinpræparater

Country Status (17)

Country Link
US (1) US20050232898A1 (es)
EP (1) EP0988861B1 (es)
JP (1) JP3641170B2 (es)
CN (1) CN1250282C (es)
AR (1) AR016504A1 (es)
AT (1) ATE260674T1 (es)
AU (2) AU767431B2 (es)
BR (1) BR9904150A (es)
CA (1) CA2280449A1 (es)
DE (1) DE69915204T2 (es)
DK (1) DK0988861T3 (es)
ES (1) ES2216447T3 (es)
HK (1) HK1026151A1 (es)
NZ (2) NZ510140A (es)
PT (1) PT988861E (es)
TW (1) TWI221773B (es)
ZA (1) ZA995201B (es)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60103940T2 (de) * 2000-02-29 2005-07-28 Pfizer Products Inc., Groton Stabilisierter Granulozyten-Kolonie-stimulierender Faktor
EP1391209A4 (en) * 2001-05-30 2009-12-16 Chugai Pharmaceutical Co Ltd PROTEIN PREPARATION
ITMI20021684A1 (it) * 2002-07-29 2004-01-29 Therapicon Srl Composizione farmaceutica di peptide nasale
ITBA20020032A1 (it) * 2002-09-24 2004-03-25 Bio D Soc Metodo per stabilizzare le proteine per la conservazione ad alte temperature.
CA2523607A1 (en) * 2003-05-09 2005-03-24 Schering Aktiengesellschaft Treatment of inflammatory respiratory diseases
SI1682184T1 (sl) * 2003-11-04 2014-02-28 Lek Pharmaceuticals D.D. Stabilen farmacevtski sestavek, obsegajoč faktor za stimulacijo kolonije granulocitov
EP1537876A1 (en) * 2003-12-01 2005-06-08 BioGeneriX AG Erythropoietin solution formulation
CA2545962A1 (en) * 2003-12-09 2005-07-07 Alcon, Inc. Use of organic buffering agents to enhance the antimicrobial activity of pharmaceutical compositions
AU2005303777B2 (en) * 2004-11-12 2010-12-16 Novo Nordisk A/S Stable formulations of insulinotropic peptides
DK1787658T3 (da) * 2005-11-10 2012-06-25 Chemi Spa Formuleringer med forsinket frigørelse og indeholdende somatostatin-analoge væksthormoninhibitorer
DE202006020194U1 (de) 2006-03-01 2007-12-06 Bioceuticals Arzneimittel Ag G-CSF-Flüssigformulierung
EP2094247B1 (en) 2006-10-20 2022-06-29 Amgen Inc. Stable polypeptide formulations
EP2471510A1 (de) 2007-08-27 2012-07-04 BioGeneriX AG Flüssigformulierung von G-CSF
JP5393690B2 (ja) * 2007-10-09 2014-01-22 ハーキュリーズ・インコーポレーテッド 架橋剤含有接着剤組成物
UA118536C2 (uk) * 2008-07-23 2019-02-11 Амбркс, Інк. Модифікований поліпептид бичачого гранулоцитарного колонієстимулювального фактора та його застосування
TWI480288B (zh) * 2010-09-23 2015-04-11 Lilly Co Eli 牛顆粒細胞群落刺激因子及其變體之調配物
ITMI20120338A1 (it) * 2012-03-06 2013-09-07 Dr Andrea Bignotti Preparato terapeutico e procedimento di preparazione di detto preparato terapeutico
GB2516808A (en) 2013-05-31 2015-02-11 Innova Biosciences Ltd Antibody composition and buffer system therefor
US11464831B2 (en) 2015-01-05 2022-10-11 Cornell University Compositions and methods using IL-8 for improving health of mammals
WO2016111992A1 (en) 2015-01-05 2016-07-14 Cornell University Compositions and methods using il-8 to improve milk production and reproductive health in mammals
US11291680B2 (en) 2016-12-15 2022-04-05 Société des Produits Nestlé S.A. Compositions and methods that modulate white blood cells or neutrophils in a companion animal
EP3771463A1 (en) 2019-07-29 2021-02-03 Ludwig-Maximilians-Universität München Stabilizing therapeutic proteins with piperazin- or morpholine-containing zwitterionic buffering substances
CN116836920B (zh) * 2023-08-21 2024-05-24 广东横琴粤澳深度合作区齐美国际干细胞医院有限公司 一种无血清培养基及其制备间充质干细胞的方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0080879B1 (en) * 1981-11-28 1986-10-01 Sunstar Kabushiki Kaisha Pharmaceutical composition containing interferon in stable state
JPS6069037A (ja) * 1983-09-26 1985-04-19 Sunstar Inc エリテマト−デス治療用外用剤
US4605555A (en) * 1984-09-20 1986-08-12 Sun Star Kabushiki Kaisha Composition and method for treating keratosic disorder of skin and mucosa
JPH0618781B2 (ja) * 1986-10-18 1994-03-16 中外製薬株式会社 感染症治療剤
JP2796388B2 (ja) * 1988-05-13 1998-09-10 アムジエン・インコーポレーテツド Ｇ−ｃｓｆの精製方法
US5013714A (en) * 1988-12-15 1991-05-07 Lindstrom Richard L Viscoelastic solution
US6066469A (en) * 1990-03-08 2000-05-23 Ferro Dynamics, Inc. Cloning, expression, and uses of human lactoferrin
DE4242919A1 (de) * 1992-12-18 1994-06-23 Boehringer Mannheim Gmbh Verfahren zur Herstellung von lagerstabilen wässrigen pharmazeutischen Zubereitungen von G-CSF
US5580856A (en) * 1994-07-15 1996-12-03 Prestrelski; Steven J. Formulation of a reconstituted protein, and method and kit for the production thereof

Also Published As

Publication number Publication date
ATE260674T1 (de) 2004-03-15
ES2216447T3 (es) 2004-10-16
JP2000063264A (ja) 2000-02-29
BR9904150A (pt) 2000-12-26
AU767431B2 (en) 2003-11-13
DE69915204T2 (de) 2004-07-29
AU2004200568A1 (en) 2004-03-11
US20050232898A1 (en) 2005-10-20
TWI221773B (en) 2004-10-11
AU4450199A (en) 2000-03-09
CN1250668A (zh) 2000-04-19
CA2280449A1 (en) 2000-02-17
ZA995201B (en) 2001-02-16
NZ510140A (en) 2005-01-28
NZ337258A (en) 2001-04-27
AR016504A1 (es) 2001-07-04
PT988861E (pt) 2004-06-30
EP0988861B1 (en) 2004-03-03
CN1250282C (zh) 2006-04-12
EP0988861A1 (en) 2000-03-29
JP3641170B2 (ja) 2005-04-20
DE69915204D1 (de) 2004-04-08
HK1026151A1 (en) 2000-12-08

Similar Documents

Publication Publication Date Title
DK0921796T3 (da) Tetrahydrolipstatinholdige præparater
DK0988861T3 (da) Stabiliserede proteinpræparater
CY2006006I2 (el) Πρωτεϊνικα σκευασματα
IS5953A (is) Lyfjablöndur úr örgerðum eplerenonum
ID24289A (id) Benzotiazol inhibitor-inhibitor protein terosin kinase
NO983364D0 (no) Konsensusproteiner
NO982097L (no) Peptider
NO982098L (no) Peptider
DE69722620D1 (de) Nicht-waessrige protische peptidzubereitungen
DE69839603D1 (de) Zierenden proteins
ATE266383T1 (de) Dermatologische zubereitungen
ATE297761T1 (de) Zubereitungen zur stabilisierung von peg- interferon alpha konjugaten
DE69827484D1 (de) Stabilisierte tibolone zubereitungen
DE59707298D1 (de) Desodorierende zubereitungen
DE69926012D1 (de) Arzneizubereitungen
DE59909255D1 (de) Kosmetische zubereitungen
ATE246494T1 (de) Brausezubereitungen
DE59908817D1 (de) Wässrige zubereitungen
ATE295417T1 (de) Angiostatin-bindendes protein
NO20004167L (no) Kaspase-8 interagerende proteiner
DK1051487T3 (da) Placentaprotein 13
DE69906934D1 (de) Arzneizubereitungen
TR199701666A3 (tr) Sismanliga karsi proteinler
NO993354D0 (no) Voksholdige preparater
NO20012283D0 (no) Koblede peptider